Fig. 3From: Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patientsa Subgroup analysis for overall survival. b Subgroup analysis for progression-free survivalBack to article page